[go: up one dir, main page]

RU93048335A - ORAL DOSAGE FORM, MATERIAL FOR THE SHELL - Google Patents

ORAL DOSAGE FORM, MATERIAL FOR THE SHELL

Info

Publication number
RU93048335A
RU93048335A RU93048335/14A RU93048335A RU93048335A RU 93048335 A RU93048335 A RU 93048335A RU 93048335/14 A RU93048335/14 A RU 93048335/14A RU 93048335 A RU93048335 A RU 93048335A RU 93048335 A RU93048335 A RU 93048335A
Authority
RU
Russia
Prior art keywords
dosage form
oral dosage
shell
active substance
cyclodextrin
Prior art date
Application number
RU93048335/14A
Other languages
Russian (ru)
Other versions
RU2116785C1 (en
Inventor
Зифке Верена
Ханштайн Улльрих
Петер Векенманн Ханс
Бауер Курт
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4236025A external-priority patent/DE4236025A1/en
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of RU93048335A publication Critical patent/RU93048335A/en
Application granted granted Critical
Publication of RU2116785C1 publication Critical patent/RU2116785C1/en

Links

Claims (1)

Изобретение касается оральной лекарственной формы, содержащей по меньшей мере одно активное вещество и по меньшей мере один покрывающий активное вещество материал, который содержит по меньшей мере одно не растворимое в воде и пищеварительных соках пленкообразующее вещество, отличающееся тем, что материал оболочки дополнительно содержит по меньшей мере один циклодекстрин и/или по меньшей мере одну из его производных.The invention relates to an oral dosage form containing at least one active substance and at least one active substance coating material that contains at least one film-forming substance insoluble in water and digestive juices, characterized in that the shell material further comprises at least one cyclodextrin and / or at least one of its derivatives.
RU93048335A 1992-10-24 1993-10-22 Oral medicinal formulation which is soluble in large bowel and an envelope material for its RU2116785C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4236025A DE4236025A1 (en) 1992-10-24 1992-10-24 Oral dosage forms
DEP4236025.0 1992-10-24

Publications (2)

Publication Number Publication Date
RU93048335A true RU93048335A (en) 1997-01-10
RU2116785C1 RU2116785C1 (en) 1998-08-10

Family

ID=6471319

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93048335A RU2116785C1 (en) 1992-10-24 1993-10-22 Oral medicinal formulation which is soluble in large bowel and an envelope material for its

Country Status (21)

Country Link
EP (1) EP0595110B1 (en)
JP (1) JPH06199702A (en)
KR (1) KR100263793B1 (en)
CN (1) CN1055617C (en)
AT (1) ATE161715T1 (en)
AU (1) AU668767B2 (en)
CA (1) CA2109026A1 (en)
CZ (1) CZ283498B6 (en)
DE (2) DE4236025A1 (en)
DK (1) DK0595110T3 (en)
ES (1) ES2113985T3 (en)
GR (1) GR3026504T3 (en)
HU (1) HU218670B (en)
MX (1) MX9306564A (en)
NO (1) NO306975B1 (en)
PL (1) PL173370B1 (en)
RU (1) RU2116785C1 (en)
SK (1) SK279774B6 (en)
TW (1) TW263439B (en)
UA (1) UA27239C2 (en)
ZA (1) ZA937876B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
DE19732903A1 (en) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet formulation for the treatment of the intestinal tract
DE19808634A1 (en) * 1998-02-24 1999-08-26 Schering Ag Production of pharmaceutical pellets, especially containing iloprost, with stabilized release properties
WO2000003697A1 (en) * 1998-07-17 2000-01-27 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
RU2147878C1 (en) * 1999-08-12 2000-04-27 Открытое акционерное общество Химико-фармацевтический комбинат "Акрихин" Pharmaceutical composition showing internal effect
AT500063A1 (en) 1999-11-23 2005-10-15 Sandoz Ag COATED TABLETS
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
UA86802C2 (en) * 2004-04-13 2009-05-25 Бёрингер Ингельхайм Интернациональ Гмбх Combination of simethicone and bisacodyl for constipated patients suffering from bloated feeling
TWI345405B (en) 2007-12-26 2011-07-11 Ind Tech Res Inst Apparatus and method for executing the handoff process in wireless networks
CN101919803A (en) * 2010-07-16 2010-12-22 钟术光 A kind of controlled release preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61129138A (en) * 1984-11-16 1986-06-17 Takeda Chem Ind Ltd Coated medicinal drug
DE4131292A1 (en) 1990-10-18 1992-04-23 Asta Pharma Ag GALACTOMAN OTHER DERIVATIVES FOR COVERING OR EMBEDDING DRUG ACTIVE SUBSTANCES
DE9015551U1 (en) 1990-11-14 1992-03-12 Röhm GmbH, 6100 Darmstadt Oral dosage form and coating agent containing a colon-degradable polysaccharide

Similar Documents

Publication Publication Date Title
IL99183A0 (en) Water soluble derivatives of taxol,processes for the preparation thereof and pharmaceutical compositions containing the same
IL101635A0 (en) Pharmaceutical compositions containing colloidal particles of water insoluble active substances
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU6770490A (en) Solid pharmaceutical compositions containing cimetidine
IT1246188B (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING INCREASED SPEED OF DISSOLUTION OF THE ACTIVE SUBSTANCE AND COMPOSITIONS OBTAINED.
FR2677984B1 (en) N-SUBSTITUTED IMIDAZOLINE DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
IE862554L (en) Pharmaceutical compositions
DE3064910D1 (en) 2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
RU93048335A (en) ORAL DOSAGE FORM, MATERIAL FOR THE SHELL
BR8905020A (en) PSYLLIUM SHELL AND PRODUCTS CONTAINING PSYLLIUM
FR2703995B1 (en) 5-ACYLAMINO 1,2,4-THIADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
HUP9900865A3 (en) Anti-viral benzimidazole derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
TW263439B (en)
RU93043304A (en) FODDER OR MEDICINAL COMPOSITIONS FOR Ruminant ANIMALS AND METHOD FOR PRODUCING THEM
IT8323058A0 (en) BIOLOGICALLY ACTIVE 2,5-PIPERAZINDION DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ATE257374T1 (en) AQUEOUS MEDICINAL PRODUCT CONTAINING AN ACTIVE COMPONENT THAT IS VERY POORLY SOLUBLE IN WATER
RU97111095A (en) PREPARATION FOR PREVENTION AND TREATMENT OF ANIMAL ANIMAL HELMINTHES "ALBAMELIN"
HU9302813D0 (en) Pharmaceutical compositions containing new benzimidazole derivatives and process for preparing the active ingredients
IT1228437B (en) "DERIVATIVES OF 2,3,4,5,6,7 HEXAIDRO 2,7-METHANE-1,5 BENZOXAZONINE (RESPECTIVELY 1,4 BENZOXAZONINE), PROCEDURE FOR THEIR PREPARATION AND MEDICINAL PRODUCTS THAT CONTAIN THESE COMPOUNDS.
FR2677250B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DISOD ADENOSINE-5-TRIPHOSPHATE.
HUP9802536A3 (en) Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer
FR2684299B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DISENTIC ADENOSINE-5-TRIPHOSPHATE AND AMILORIDE.
FR2673944B1 (en) DERIVATIVES OF 1,8-NAPHTALIMIDE, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ZA928126B (en) Use of substituted tetrahydrothiophenes, some of wich are known as medicaments, new active substances and processes for their preparation.